Literature DB >> 29987595

Prognostic significance of atrial fibrillation in acute decompensated heart failure with reduced versus preserved ejection fraction.

Alexander Jobs1,2, Julia Schwind3, Alexander Katalinic4, Valentin Babaev4, Roland Richard Tilz3,5, Stefan Rausch3, Holger Thiele6, Ingo Eitel3,5, Charlotte Eitel3,5.   

Abstract

OBJECTIVE: The prognostic impact of atrial fibrillation (AF) in patients with acute decompensated heart failure (ADHF) has not been fully elucidated yet. Aim of the present study was thus to investigate the association of AF with all-cause mortality in patients with reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF).
METHODS: We performed a retrospective single center study and analyzed data of 1286 patients admitted for ADHF. Patients were grouped according to AF status (i.e., "never AF", "history of AF", or "AF on admission") and type of heart failure. Patient and treatment characteristics were extracted by chart review. The primary outcome of all-cause mortality within 3 years following index hospitalization was determined by death registry linkage.
RESULTS: In total, 529 (41.1%), 215 (16.7%), and 542 (42.1%) patients were grouped as "never AF", "history of AF", and "AF on admission", respectively. With regard to type of heart failure, 558 (43.4%) and 728 (56.6%) had HFrEF and HFpEF, respectively. Compared to "never AF", "AF on admission" was associated with increased all-cause mortality in an adjusted Cox regression model [hazard ratio, 1.64 (95% confidence interval 1.32-2.04); P < 0.001]. However, this association remained significant only for patients with HFpEF [2.16 (1.58-2.95)], but not for patients with HFrEF [1.18 (0.85-1.63)] in a subgroup analysis (P for effect modification = 0.020).
CONCLUSIONS: AF is common in the setting of ADHF and is associated with increased all-cause mortality. However, this association remained significant only in patients with HFpEF, but not in patients with HFrEF.

Entities:  

Keywords:  Acute decompensated heart failure; Atrial fibrillation; Heart failure with preserved ejection fraction; Heart failure with reduced ejection fraction

Mesh:

Year:  2018        PMID: 29987595     DOI: 10.1007/s00392-018-1321-4

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  9 in total

1.  Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1.

Authors:  Lukas Chmielewski; Michael Bietenbeck; Alexandru Patrascu; Sabine Rösch; Udo Sechtem; Ali Yilmaz; Anca-Rezeda Florian
Journal:  Clin Res Cardiol       Date:  2019-02-14       Impact factor: 5.460

2.  Prognostic impact of recurrences of ventricular tachyarrhythmias and appropriate ICD therapies in a high-risk ICD population.

Authors:  Tobias Schupp; Ibrahim Akin; Linda Reiser; Armin Bollow; Gabriel Taton; Thomas Reichelt; Dominik Ellguth; Niko Engelke; Uzair Ansari; Kambis Mashayekhi; Christel Weiß; Christoph Nienaber; Muharrem Akin; Martin Borggrefe; Michael Behnes
Journal:  Clin Res Cardiol       Date:  2019-02-12       Impact factor: 5.460

3.  Body mass index and all-cause mortality in patients with atrial fibrillation: insights from the China atrial fibrillation registry study.

Authors:  Lu Wang; Xin Du; Jian-Zeng Dong; Wen-Na Liu; Ying-Chun Zhou; Song-Nan Li; Xue-Yuan Guo; Chen-Xi Jiang; Rong-Hui Yu; Cai-Hua Sang; Ri-Bo Tang; De-Yong Long; Nian Liu; Rong Bai; Laurent Macle; Chang-Sheng Ma
Journal:  Clin Res Cardiol       Date:  2019-04-05       Impact factor: 5.460

4.  Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid-range and preserved ejection fraction.

Authors:  Gijs van Woerden; Dirk J van Veldhuisen; Thomas M Gorter; Vanessa P M van Empel; Martin E W Hemels; Eric J Hazebroek; Sophie L van Veldhuisen; Tineke P Willems; Michiel Rienstra; Berend Daan Westenbrink
Journal:  Clin Cardiol       Date:  2021-06-04       Impact factor: 2.882

Review 5.  Association between atrial fibrillation and Helicobacter pylori.

Authors:  Cecilia Tetta; Amalia Ioanna Moula; Francesco Matteucci; Orlando Parise; Bart Maesen; Daniel Johnson; Mark La Meir; Sandro Gelsomino
Journal:  Clin Res Cardiol       Date:  2019-02-08       Impact factor: 5.460

6.  Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network study.

Authors:  Prathap Kanagala; Iain B Squire; Donald J L Jones; Thong Huy Cao; Daniel C S Chan; Gerry McCann; Jatinderpal K Sandhu; Paulene A Quinn; John McAdam; Anna-Marie Marsh; Joan E Davies; Joachim Struck; Andreas Bergmann; Zaid Sabti; Raphael Twerenbold; Thomas Herrmann; Nikola Kozhuharov; Christian Mueller; Leong L Ng
Journal:  Clin Res Cardiol       Date:  2019-02-14       Impact factor: 5.460

7.  Clinical characteristics and in-hospital outcomes of acute decompensated heart failure patients with and without atrial fibrillation.

Authors:  Umut Kocabaş; Ümit Yaşar Sinan; Emre Aruğaslan; Mustafa Kurşun; Ali Çoner; Özlem Özcan Çelebi; Cengiz Öztürk; Onur Dalgıç; Ebru Ipek Türkoğlu; Hatice Soner Kemal; Emine Gazi; Cihan Altın; Mehdi Zoghi
Journal:  Anatol J Cardiol       Date:  2020-04       Impact factor: 1.596

8.  Characteristics and long-term prognosis of patients with reduced, mid-range, and preserved ejection fraction: A systemic review and meta-analysis.

Authors:  Min Liang; Bo Bian; Qing Yang
Journal:  Clin Cardiol       Date:  2022-01-18       Impact factor: 2.882

9.  Frequency of Atrial Fibrillation in Patients Presenting With Decompensated Heart Failure.

Authors:  Rafi Ullah; Ahmad Shiraz; Sher Bahadur; Farhat Shireen
Journal:  Cureus       Date:  2021-12-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.